Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.92 HKD
Change Today -0.01 / -1.08%
Volume 4.9M
As of 4:01 AM 05/27/15 All times are local (Market data is delayed by at least 15 minutes).

ck life sciences intl hldgs (775) Snapshot

Open
$0.93
Previous Close
$0.93
Day High
$0.93
Day Low
$0.91
52 Week High
05/18/15 - $0.97
52 Week Low
05/27/14 - $0.72
Market Cap
8.8B
Average Volume 10 Days
17.0M
EPS TTM
$0.03
Shares Outstanding
9.6B
EX-Date
05/20/15
P/E TM
33.6x
Dividend
$0.0080
Dividend Yield
0.87%
Current Stock Chart for CK LIFE SCIENCES INTL HLDGS (775)

Related News

No related news articles were found.

ck life sciences intl hldgs (775) Related Businessweek News

No Related Businessweek News Found

ck life sciences intl hldgs (775) Details

CK Life Sciences Int'l., (Holdings) Inc., an investment holding company, engages in the research and development, manufacture, commercialization, marketing, and sale of health and agriculture-related products in the Asia Pacific and North America. It manufactures and markets plant protection products and soluble fertilizers; manufactures, blends, distributes, and sells fertilizers, pesticides, and related agricultural products; manufactures and distributes horticultural products for the home gardening market; and contract manufactures complementary healthcare medicines and produces non-sterile prescription and over-the-counter medicines. The company is also involved in licensing registration activities and the importation of finished agricultural goods; holding land and building; financing and trustee activities; investment in financial instruments, as well as vineyards and wineries; trading biotechnology products and nutritional supplements; and the manufacture, wholesale, retail, and distribution of nutraceutical products. In addition, it distributes turf management machinery, hardware, equipment, and accessories, as well as chemicals and professional pest products; produces, refines, and distributes salt products; and provides services in the research and development of bio-technology and life sciences technology products. The company’s products include emulsifiable concentrates, suspension concentrates, aqueous solutions, coated granules, powders, and amination based reactions for crop protection; and pharmaceutical products, such as Tetrodotoxin and POL-103A that are in advanced stages of clinical development for the treatment of cancer, as well as cosmetics. Further, it engages in the discovery, development, manufacture, and commercialization of drug products to treat pain; development of Melanoma vaccine, which is in Phase III clinical trial; and supply of raw materials for various segments. The company is headquartered in Tai Po, Hong Kong.

1,675 Employees
Last Reported Date: 03/30/15

ck life sciences intl hldgs (775) Top Compensated Officers

Chief Operating Officer, Vice President, Comp...
Total Annual Compensation: $9.7M
Chief Scientific Officer, Vice President and ...
Total Annual Compensation: $6.2M
Compensation as of Fiscal Year 2014.

ck life sciences intl hldgs (775) Key Developments

CK Life Sciences Int'l., (Holdings) Inc. expected to report Q1 2015 results on May 26, 2015. This event was calculated by Capital IQ (Created on May 20, 2015).

CK Life Sciences Int'l., (Holdings) Inc. expected to report Q1 2015 results on May 26, 2015. This event was calculated by Capital IQ (Created on May 20, 2015).

CK Life Sciences Int'l., (Holdings) Inc. Announces Executive Changes

The board of directors of CK Life Sciences Int'l., (Holdings) Inc. announced that Professor Wong Yue-chim, Richard has retired as an Independent Non-executive Director of the company with effect from the close of the annual general meeting of the company held on May 15, 2015 and did not offer himself for re-election at the AGM. Upon his retirement, Professor Wong also ceased to be the Chairman of the Audit Committee of the company. The Board further announced that Mr. Kwan Kai Cheong, an Independent Non-executive Director of the company, has been appointed as the Chairman of the Audit Committee with effect from May 15, 2015 following the retirement of Professor Wong.

CK Life Sciences Int'l., (Holdings) Inc. Reports Audited Consolidated Earnings Results for the Year Ended December 31, 2014

CK Life Sciences Int'l., (Holdings) Inc. reported audited consolidated earnings results for the year ended December 31, 2014. For the year, the company reported turnover of HKD 4,954,043,000 compared to HKD 4,970,927,000 reported a year ago. Profit before taxation was HKD 321,130,000 compared to HKD 303,729,000 reported a year ago. Profit attributable to shareholders of the company was HKD 263,558,000 or 2.74 cents per diluted share compared to HKD 229,008,000 or 2.38 cents per diluted share reported a year ago. Purchases of property, plant and equipment were HKD 140,861,000 compared to HKD 139,594,000 reported a year ago. Purchases of investment properties were HKD 210,725,000 compared to HKD 98,865,000 reported a year ago. Purchases of vines were HKD 138,326,000 compared to HKD 47,851,000 reported a year ago. Additions to intangible assets were HKD 5,603,000 compared to HKD 31,109,000 reported a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
775:HK $0.92 HKD -0.01

775 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CK Hutchison Holdings Ltd $118.20 HKD -46.90
Henderson Land Development Co Ltd $63.60 HKD -1.65
Real Nutriceutical Group Ltd $2.83 HKD +0.03
Tom Group Ltd $2.55 HKD -0.13
View Industry Companies
 

Industry Analysis

775

Industry Average

Valuation 775 Industry Range
Price/Earnings 33.9x
Price/Sales 1.8x
Price/Book 1.9x
Price/Cash Flow 27.0x
TEV/Sales 0.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CK LIFE SCIENCES INTL HLDGS, please visit www.ck-lifesciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.